Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Lymphoma, Follicular 3 Sarcoma 2 Neoplasms 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Philadelphia Chromosome 1 Multiple Myeloma 1 Meningeal Carcinomatosis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Kidney Neoplasms 1 Influenza, Human 1 Hepatitis B, Chronic 1 Hepatitis B 1 Heartburn 1 Gastrointestinal Cancer Metastatic 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

fludarabine phosphate 24 Peripheral Blood Stem Cell Transplantation 21 Cyclophosphamide 21 Busulfan 19 Whole-Body Irradiation 15 Tacrolimus 15 Mycophenolic Acid 13 Methotrexate 12 ruxolitinib 11 Cyclosporine 10 Antilymphocyte Serum 10 fludarabine 8 Melphalan 7 peginterferon alfa-2a 6 Aspirin 6 Filgrastim 5 Stem Cell Transplantation 4 Radiotherapy 4 Imatinib Mesylate 4 Hydroxyurea 4 Flow Cytometry 4 Etoposide 4 Decitabine 4 Biopsy 4 Azacitidine 4 Thiotepa 3 Surveys and Questionnaires 3 Prednisone 3 Methylprednisolone 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycythemia Vera × Interferons × Clear all

NCT04116502 2026-04-28

MITHRIDATE

University of Birmingham

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡